Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22,052 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expert consensus on perioperative integrated skincare for noninvasive energy-based device aesthetic procedures in clinical practice in China.
Zhang C, Song W, Yu B, Chen X, Fan W, Gao L, Gu J, Hao F, He W, Ju Q, Li H, Liu H, Liang H, Li K, Li S, Lin T, Liu W, Li X, Liu Z, Qin X, Ren J, Wang B, Wu W, Wang W, Xu X, Xie H, Yang B, Yuan C, Yan Y, Zhang W, Zhang W, Zou Y, Zhao X, Zheng Z, Zhou Z, Wu Y, Xiang L. Zhang C, et al. Among authors: yang b. J Eur Acad Dermatol Venereol. 2024 Jul;38 Suppl 6:26-36. doi: 10.1111/jdv.19857. Epub 2024 Feb 29. J Eur Acad Dermatol Venereol. 2024. PMID: 38419560
Risk of Congenital Syphilis (CS) Following Treatment of Maternal Syphilis: Results of a CS Control Program in China.
Hong FC, Wu XB, Yang F, Lan LN, Guan Y, Zhang CL, Feng TJ, Yang YZ, Yin YP, Yu WY, Chen XS; Shenzhen Program for Prevention of Congenital Syphilis (SPPCS) Collaborative Team; Shenzhen Program for Prevention of Congenital Syphilis (SPPCS) Collaborative Team. Hong FC, et al. Clin Infect Dis. 2017 Aug 15;65(4):588-594. doi: 10.1093/cid/cix371. Clin Infect Dis. 2017. PMID: 28444157
Efficacy and safety of topical minocycline foam (FMX101 4%) in treatment of Chinese subjects with moderate-to-severe facial acne vulgaris: A phase 3, multi-centre, randomized, double-blind, vehicle-controlled study.
Le Y, Yang W, Lu J, Jiang X, Guo Q, Huang C, Sun Q, Wang H, Bi M, Wang H, Geng S, Yang B, Xu AE, Cui Y, Man X, Zhao Y, Zhang L, Li L, Song Z, Chen J, Cheng H, Zhu W, Han X, Li S, Lin T, Zhang C, Li J, Li Y, Ding Y, Wang L, Zhu Y, Xiang L. Le Y, et al. Among authors: yang b, yang w. J Eur Acad Dermatol Venereol. 2024 Jul 1. doi: 10.1111/jdv.20159. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38948962
Tildrakizumab for moderate-to-severe plaque psoriasis in Chinese patients: A 12-week randomized placebo-controlled phase III trial with long-term extension.
Yu C, Geng S, Yang B, Deng Y, Li F, Kang X, Bi M, Zhang F, Zhao Y, Pan W, Tian Z, Xu J, Zhang Z, Yu N, Duan X, Guo S, Sun Q, Li W, Tao J, Liu Z, Yin Y, Wang G. Yu C, et al. Among authors: yang b. Chin Med J (Engl). 2024 May 20;137(10):1190-1198. doi: 10.1097/CM9.0000000000002873. Epub 2024 Jan 9. Chin Med J (Engl). 2024. PMID: 38192233 Free PMC article. Clinical Trial.
22,052 results
You have reached the last available page of results. Please see the User Guide for more information.